---
title: "TONGDA GROUP: Tongda Smart Tech's net profit attributable to the parent company for the first three quarters was 80.46 million yuan, a year-on-year decrease of 4.1%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263496117.md"
description: "According to the Zhitong Finance APP, TONGDA GROUP released the performance of Tongda Smart Tech for the first 9 months of 2025, with revenue of approximately 822 million yuan, a year-on-year increase of 15%; the net profit attributable to the equity owners of Tongda Smart Tech was 80.46 million yuan, a year-on-year decrease of 4.1%"
datetime: "2025-10-30T11:01:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263496117.md)
  - [en](https://longbridge.com/en/news/263496117.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263496117.md)
generator: "portal-rs"
---

# TONGDA GROUP: Tongda Smart Tech's net profit attributable to the parent company for the first three quarters was 80.46 million yuan, a year-on-year decrease of 4.1%

According to the Zhitong Finance APP, TONGDA GROUP (00698) released the performance of Tongda Smart Tech for the first nine months of 2025, with revenue of approximately 822 million yuan, a year-on-year increase of 15%; the net profit attributable to the equity owners of Tongda Smart Tech was 80.46 million yuan, a year-on-year decrease of 4.1%

### Related Stocks

- [001368.CN](https://longbridge.com/en/quote/001368.CN.md)
- [00698.HK](https://longbridge.com/en/quote/00698.HK.md)

## Related News & Research

- [Zhongji Innolight Co.: Revenue and profit surged on booming global AI demand and successful Hong Kong listing](https://longbridge.com/en/news/296610520.md)
- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [Pakistani port promises 70 new electric trucks in $76M ZEV push](https://longbridge.com/en/news/296831514.md)
- [Kingsoft Cloud Holdings (KC) Q2 Profit Turn As AI Cloud Growth Puts Valuation In Focus](https://longbridge.com/en/news/296452812.md)
- [SBP GROUP 's Innovative ActRII A/B Monoclonal Antibody Approved for Clinical Study](https://longbridge.com/en/news/296699167.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**